“The impact of Taq1A ANKK1/DRD2 Polymorphism on Dopamine in Individuals with Amphetamine Use Disorder in Basra, Iraq” (2025) Genetics and Molecular Research, 24(4), pp. 1–12. doi:10.4238/c4y77n43.